Novocure Ltd (NVCR) support and resistance · rev $357.6M
Novocure Ltd (NVCR) is a medical devices company listed on US.
This page maps Novocure Ltd (NVCR) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported NVCR revenue for 2026-06-30 was $357.6M. Net income was -$86.8M. NVCR currently screens at market cap $1.99B.
NVCR currently screens at market cap $1.99B. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new NVCR 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the NVCR quote page for the session range and the stock page for the full model.
Not investment advice.